| (INR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 9.38B | — |
| Operating expense | — | — |
| Net income | 2.37B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, GLAXO.NS returned +6.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +20.3% |
| 1 year | +6.3% |
| 5 years | +120.2% |
| 10 years | +141.8% |
| All-time high | ₹3,388.10 (Jun 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in GLAXO.NS would be worth today ›Yes. GlaxoSmithKline Pharmaceuticals Limited paid 1 dividend over the past 12 months. The most recent was ₹57.00 per share on May 29, 2026. The dividend yield is 1.96%.
GlaxoSmithKline Pharmaceuticals Limited is part of the Healthcare sector.
GlaxoSmithKline Pharmaceuticals Limited has a market cap of 496.65B INR, based on the latest quote.
